Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing

被引：0
|
作者：
Foley, Georgea R. [1 ]
Marthick, James R. [1 ]
Ostrander, Elaine A. [2 ]
Stanford, Janet L. [3 ]
Dickinson, Joanne L. [1 ]
FitzGerald, Liesel M. [1 ,4 ]
机构：
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia
[2] Natl Human Genome Res Inst, NIH, Canc Genet & Comparat Genom Branch, Bethesda, MD 20892 USA
[3] Fred Hutchinson Canc Ctr, 1100 Fairview Ave N,M4-B874, Seattle, WA 98109 USA
[4] Univ Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia
来源：
EUROPEAN JOURNAL OF CANCER | 2023年 / 180卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.ejca.2022.11.034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：155 / 157
页数：3
相关论文
共 50 条
  • [1] Loss of heterozygosity at the BRCA2 locus is a common finding in prostate cancer in men with a germline BRCA2 mutation
    Dawson, S.
    Willems, A.
    Thorne, H.
    Samaratunga, H.
    Antill, Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
    S M Edwards
    D G R Evans
    Q Hope
    A R Norman
    Y Barbachano
    S Bullock
    Z Kote-Jarai
    J Meitz
    A Falconer
    P Osin
    C Fisher
    M Guy
    S G Jhavar
    A L Hall
    L T O'Brien
    B N Gehr-Swain
    R A Wilkinson
    M S Forrest
    D P Dearnaley
    A T Ardern-Jones
    E C Page
    D F Easton
    R A Eeles
    British Journal of Cancer, 2010, 103 : 918 - 924
  • [3] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
    Edwards, S. M.
    Evans, D. G. R.
    Hope, Q.
    Norman, A. R.
    Barbachano, Y.
    Bullock, S.
    Kote-Jarai, Z.
    Meitz, J.
    Falconer, A.
    Osin, P.
    Fisher, C.
    Guy, M.
    Jhavar, S. G.
    Hall, A. L.
    O'Brien, L. T.
    Gehr-Swain, B. N.
    Wilkinson, R. A.
    Forrest, M. S.
    Dearnaley, D. P.
    Ardern-Jones, A. T.
    Page, E. C.
    Easton, D. F.
    Eeles, R. A.
    BRITISH JOURNAL OF CANCER, 2010, 103 (06) : 918 - 924
  • [4] A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report
    Jiang, Lijuan
    Bai, Zunguang
    Zhu, Shoulun
    Zhao, Tingting
    Yang, Yining
    Li, Zhiyong
    Chen, Dong
    Wu, Zhiming
    Wang, Yanjun
    Zhou, Fangjian
    Li, Yonghong
    BMC UROLOGY, 2021, 21 (01)
  • [5] A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report
    Lijuan Jiang
    Zunguang Bai
    Shoulun Zhu
    Tingting Zhao
    Yining Yang
    Zhiyong Li
    Dong Chen
    Zhiming Wu
    Yanjun Wang
    Fangjian Zhou
    Yonghong Li
    BMC Urology, 21
  • [6] Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers
    Milne, R. L.
    Antoniou, A. C.
    ANNALS OF ONCOLOGY, 2011, 22 : i11 - i17
  • [7] Treatment-related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib
    Ikeda, Riko
    Matsuoka, Yoh
    Inoue, Masaharu
    Ishikawa, Ayataka
    Akagi, Kiwamu
    Kageyama, Yukio
    IJU CASE REPORTS, 2024, 7 (02) : 115 - 119
  • [8] Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
    Lozano, Rebeca
    Castro, Elena
    -Campos, Fernando Lopez
    Thorne, Heather
    Ramirez-Backhaus, Miguel
    Aragon, Isabel M.
    Cendon-Florez, Ylenia
    Gutierrez-Pecharroman, Ana
    Salles, Daniela C.
    Romero-Laorden, Nuria
    Lorente, David
    Gonzalez-Peramato, Pilar
    Calatrava, Ana
    Alonso, Concepcion
    Anido, Urbano
    Arevalo-Lobera, Sara
    Balmana, Judith
    Chirivella, Isabel
    Juan-Fita, Maria Jose
    Llort, Gemma
    Cajal, Teresa Ramon Y.
    Almagro, Elena
    Alameda, Daniel
    Lopez-Casas, Pedro P.
    Herrera, Bernardo
    Mateo, Joaquin
    Pritchard, Colin C.
    Antonarakis, Emmanuel S.
    Lotan, Tamara L.
    Rubio-Briones, Jose
    Sandhu, Shahneen
    Olmos, David
    EUROPEAN JOURNAL OF CANCER, 2023, 185 : 105 - 118
  • [9] BRCA2 mutation in Icelandic prostate cancer patients
    Stefan Sigurdsson
    Steinunn Thorlacius
    J. Tomasson
    Laufey Tryggvadottir
    Kristrun Benediktsdottir
    J. E. Eyfjörd
    Eirikur Jonsson
    Journal of Molecular Medicine, 1997, 75 : 758 - 761
  • [10] The influence of BRCA2 mutation on localized prostate cancer
    Taylor, Renea A.
    Fraser, Michael
    Rebello, Richard J.
    Boutros, Paul C.
    Murphy, Declan G.
    Bristow, Robert G.
    Risbridger, Gail P.
    NATURE REVIEWS UROLOGY, 2019, 16 (05) : 281 - 290
12345